Particle.news

Download on the App Store

Torrent Pharma Delivers 11% Q1 Revenue Growth as Citi Raises Price Target

With robust results boosting margins, Citi Research raised its target to Rs 4,380

Overview

  • Torrent reported Q1 FY26 consolidated revenue of Rs 3,178 crore, up 11% year-on-year
  • Net profit climbed 20% to Rs 548 crore, led by strong performance in domestic chronic therapies
  • Operating EBITDA rose 14% to Rs 1,032 crore, lifting the margin to 32.5%
  • International sales expanded across key markets with U.S. revenue up 19%, Brazil up 11% and Germany up 9%
  • Shares closed 0.7% higher on the NSE and Citi Research upped its price target from Rs 4,000 to Rs 4,380 with a buy rating